相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Multi-range ERK responses shape the proliferative trajectory of single cells following oncogene induction
Jia-Yun Chen et al.
CELL REPORTS (2023)
The small-molecule BMH-21 directly inhibits transcription elongation and DNA occupancy of RNA polymerase I in vivo and in vitro
Ruth Q. Jacobs et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2022)
Senolytic elimination of Cox2-expressing senescent cells inhibits the growth of premalignant pancreatic lesions
Dror Kolodkin-Gal et al.
GUT (2022)
The NAMPT Inhibitor FK866 Increases Metformin Sensitivity in Pancreatic Cancer Cells
Maxime Parisotto et al.
CANCERS (2022)
A hydride transfer complex reprograms NAD metabolism and bypasses senescence
Sebastian Igelmann et al.
MOLECULAR CELL (2021)
Early nucleolar responses differentiate mechanisms of cell death induced by oxaliplatin and cisplatin
Emily C. Sutton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Nucleolar RNA polymerase II drives ribosome biogenesis
Karan J. Abraham et al.
NATURE (2020)
An In Vivo Kras Allelic Series Reveals Distinct Phenotypes of Common Oncogenic Variants
Maria Paz Zafra et al.
CANCER DISCOVERY (2020)
Transcriptional suppression of ribosomal DNA with phase separation
Satoru Ide et al.
SCIENCE ADVANCES (2020)
Hyperactivation of MAPK Signaling Is Deleterious to RAS/RAF-mutant Melanoma
Grace P. Leung et al.
MOLECULAR CANCER RESEARCH (2019)
First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematologic Cancers: Results of a Phase I Dose-Escalation Study
Amit Khot et al.
CANCER DISCOVERY (2019)
Circumventing senescence is associated with stem cell properties and metformin sensitivity
Xavier Deschenes-Simard et al.
AGING CELL (2019)
Senescence-associated reprogramming promotes cancer stemness
Maja Milanovic et al.
NATURE (2018)
c-MYC G-quadruplex binding by the RNA polymerase I inhibitor BMH-21 and analogues revealed by a combined NMR and biochemical Approach
Loana Musso et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2018)
Senescence-associated ribosome biogenesis defects contributes to cell cycle arrest through the Rb pathway
Frederic Lessard et al.
NATURE CELL BIOLOGY (2018)
ZNF185 is a p53 target gene following DNA damage
Artem Smirnov et al.
AGING-US (2018)
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
T. Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Hyperactivation of ERK by multiple mechanisms is toxic to RTK-RAS mutation-driven lung adenocarcinoma cells
Arun M. Unni et al.
ELIFE (2018)
Ribosome biogenesis in cancer: new players and therapeutic avenues
Joffrey Pelletier et al.
NATURE REVIEWS CANCER (2018)
Proteomic profiling reveals DNA damage, nucleolar and ribosomal stress are the main responses to oxaliplatin treatment in cancer cells
Tomas Ozdian et al.
JOURNAL OF PROTEOMICS (2017)
Steady-State Levels of Phosphorylated Mitogen-Activated Protein Kinase Kinase 1/2 Determined by Mortalin/HSPA9 and Protein Phosphatase 1 Alpha in KRAS and BRAF Tumor Cells
Pui-Kei Wu et al.
MOLECULAR AND CELLULAR BIOLOGY (2017)
Cancer drug addiction is relayed by an ERK2-dependent phenotype switch
Xiangjun Kong et al.
NATURE (2017)
A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress
Peter M. Bruno et al.
NATURE MEDICINE (2017)
Coexisting Liquid Phases Underlie Nucleolar Subcompartments
Marina Feric et al.
CELL (2016)
Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia
Seyedmehdi Shojaee et al.
CANCER CELL (2015)
A localized nucleolar DNA damage response facilitates recruitment of the homology-directed repair machinery independent of cell cycle stage
Marjolein van Sluis et al.
GENES & DEVELOPMENT (2015)
ERK2 Mediates Metabolic Stress Response to Regulate Cell Fate
Sejeong Shin et al.
MOLECULAR CELL (2015)
Promiscuous interactions and protein disaggregases determine the material state of stress-inducible RNP granules
Sonja Kroschwald et al.
ELIFE (2015)
Targeting the nucleolus for cancer intervention
Jaclyn E. Quin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
A Targeting Modality for Destruction of RNA Polymerase I that Possesses Anticancer Activity
Karita Peltonen et al.
CANCER CELL (2014)
ERKs in Cancer: Friends or Foes?
Xavier Deschenes-Simard et al.
CANCER RESEARCH (2014)
MAPK Signaling Is Required for Dedifferentiation of Acinar Cells and Development of Pancreatic Intraepithelial Neoplasia in Mice
Meredith A. Collins et al.
GASTROENTEROLOGY (2014)
PPARβ/δ promotes HRAS-induced senescence and tumor suppression by potentiating p-ERK and repressing p-AKT signaling
B. Zhu et al.
ONCOGENE (2014)
Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation
Xavier Deschenes-Simard et al.
GENES & DEVELOPMENT (2013)
Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer
M. E. Caldwell et al.
ONCOGENE (2012)
STAT3 Plays a Critical Role in KRAS-Induced Pancreatic Tumorigenesis
Ryan B. Corcoran et al.
CANCER RESEARCH (2011)
The Incorporation of 5-Fluorouracil into RNA Affects the Ribonucleolytic Activity of the Exosome Subunit Rrp6
Rebecca A. Silverstein et al.
MOLECULAR CANCER RESEARCH (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Cellular senescence predicts treatment outcome in metastasised colorectal cancer
A. M. Haugstetter et al.
BRITISH JOURNAL OF CANCER (2010)
Loss of Topoisomerase I leads to R-loop-mediated transcriptional blocks during ribosomal RNA synthesis
Aziz El Hage et al.
GENES & DEVELOPMENT (2010)
Phenotype and Genotype of Pancreatic Cancer Cell Lines
Emily L. Deer et al.
PANCREAS (2010)
KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma
John P. Morris et al.
NATURE REVIEWS CANCER (2010)
Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity
Yasser Pereira et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Pancreatic Intraepithelial Neoplasia Revisited and Updated
B. Sipos et al.
PANCREATOLOGY (2009)
Human tumor suppressor p14ARF negatively regulates rRNA transcription and inhibits UBF1 transcription factor phosphorylation
O. Ayrault et al.
ONCOGENE (2006)
CK2-mediated stimulation of Pol I transcription by stabilization of UBF-SL1 interaction
Chih-Yin Lin et al.
NUCLEIC ACIDS RESEARCH (2006)
Loss of the VHR dual-specific phosphatase causes cell-cycle arrest and senescence
S Rahmouni et al.
NATURE CELL BIOLOGY (2006)
Both p16Ink4a and the p19Arf-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse
N Bardeesy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Dynamic sorting of nuclear components into distinct nucleolar caps during transcriptional inhibition
Y Shav-Tal et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
High intensity ras signaling induces premature senescence by activating p38 pathway in primary human fibroblasts
QD Deng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
An illustrated consensus on the classification of pancreatic Intraepithelial neoplasia and intraductal papillary mucinous neoplasms
RH Hruban et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2004)
Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity
P Loukopoulos et al.
PANCREAS (2004)
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
SR Hingorani et al.
CANCER CELL (2003)
Phosphorylation of UBF at serine 388 is required for interaction with RNA polymerase I and activation of rDNA transcription
R Voit et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
